Amicus Therapeutics Inc (FOLD) Return on Assets ROA from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Amicus Therapeutics inc   (NASDAQ: FOLD)


Amicus Therapeutics Inc 's ROA from the fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Amicus Therapeutics Inc 's ROA in the fourth quarter of 2025?
Amicus Therapeutics Inc recorded a cumulative net loss of $-27 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on assets (ROA) of -3.17%.

However, within the Healthcare sector 280 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from 2796 to 3310.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Total Assets Change 21 % 10.46 % 8.78 % 9.43 % 0.92 %
Y / Y Net Income Change -88.53 % - - - -
Net Income (TTM) in million -27 -14 -38 -29 -56
Return On Assets (TTM) -3.17 % -1.73 % -4.8 % -3.78 % -7.38 %
FOLD's Total Ranking # 3310 # 2796 # 3025 # 2980 # 3718
Total Assets (TTM) in million 950 869 815 790 785
Seq. Total Assets Change 9.33 % 6.56 % 3.22 % 0.61 % -0.19 %
Seq. Net Income Change -90.23 % - - - -

FOLD's 5 Years Annual ROA >> Back to FOLD Management Effectiveness >> Compare FOLD ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 103
Sector # 281
Overall # 3282

Return On Assets Statistics
High Average Low
-1.73 %
-32.8 %
-64.73 %
(Sep 30 2025)   (Sep 30 2013)





Financial Statements
Amicus Therapeutics Inc 's Assets $ 950 million FOLD's Balance sheet
Amicus Therapeutics Inc 's Income $ 2 million Quarterly FOLD's Income Statement
FOLD's Income by Division See FOLD's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 21 % 0.92 % 7.42 % -19.99 % -54.58 %
Total Assets in million 950 785 778 724 905
Y / Y Net Income Change - - - - -
Net Income in million -27 -56 -152 -237 -250
Annual Return On Assets -2.85 % -7.15 % -19.49 % -32.67 % -27.67 %

FOLD's 5 Years Annual ROA >> Back to FOLD Management Effectiveness >> Compare FOLD ROA to its Competitors



More Return On Assets Ratios
FOLD's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
FOLD's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for FOLD's Competitors
Subscribers only: Roa for Amicus Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for FOLD's Customers

You may also want to know
FOLD's Roi FOLD's Inventory Turnover Ratio FOLD's Growth Rates FOLD's Dividend Comparisons
FOLD's Profitability Ratios FOLD's Asset Turnover Ratio FOLD's Dividend Growth
FOLD's Roe FOLD's Valuation Ratios FOLD's Financial Strength Ratios FOLD's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector ROA

Date modified: 2026-06-22T14:32:45+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.